Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial

Abstract

BCT and mastectomy demonstrate similar survival rates in a trial in which the great majority of the patients had stage II breast cancer.

Outcomes of Triple-Negative Versus Non-Triple-Negative Breast Cancers Managed with Breast-Conserving Therapy

“…Expected 5 year locoregional recurrence free, disease free and overall survival was also comparable between TNBC versus Non-TNBC patients. With a median follow up of more than four years, locoregional recurrence rate was comparable with randomized trials of BCT versus mastectomy (Van et al, 2000;Fischer et al, 2002).…”

The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study

“…Large prospective randomized trials have demonstrated that the survival rates after BCT are equivalent to those obtained after radical mastectomy [1][2][3]. The 5-year local-recurrence rate after BCT is about 5% with survival rates of approximately 92% [2][3][4][5].…”

Atrial Fibrillation and Cor Triatriatum Sinister: A Case Report

“…252 With this change came the increased use of RT as the preferred adjunctive approach in procedures that aim to conserve the breast. [59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75] Survival has increased with BCT and RT, and therefore the use of RT has grown exponentially. Long-term side effects of RT assume an increasingly important role in the development of SPMs.…”